李忱;刘晋河;董振华;

• 1:中国医学科学院北京协和医学院北京协和医院中医科

摘要(Abstract)：

<正>辅助性T细胞17(T helper cell 17,Th17)和调节性T细胞(regulatory T cells,Treg)是近年来发现的两类CD4+T细胞亚群,目前认为Th17具有明显促进炎症的作用,引起组织炎性病理损伤;而Treg细胞具有抑制免疫反应的作用,维持机体的免疫耐受,两者对立统一,维持着机体平衡。Th17/Treg细胞平衡在自身免疫性疾病,尤其是类风湿关节炎免疫调节中

关键词(KeyWords)： 辅助性T细胞17;调节性T细胞;免疫调节;类风湿关节炎

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 李忱;刘晋河;董振华;

参考文献(References)：

• [1]Aarvak T,Chabaud M,Miossec P,et al.IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells[J].J Immunol,1999,162:1246-1251.
• [2]Wang W,Shao S,Jiao Z,et al.The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis[J].Rheumatol Int,2012,32:887-893.
• [3]Miossec P,Korn T,Kuchroo VK.Interleukin-17 and type 17helper T cells[J].N Engl J Med,2009,361:888-898.
• [4]Chabaud M,Durand JM,Buchs N,et al.Human interleukin-17:a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium[J].Arthritis Rheum,1999,42:963-970.
• [5]Ziolkowska M,Koc A,Luszczykiewicz G,et al.High levels of IL-17 in rheumatoid arthritis patients:IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism[J].J Immunol,2000,164:2832-2838.
• [6]Koenders MI,Joosten LA,van den Berg WB.Potential new targets in arthritis therapy:interleukin(IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis[J].Ann Rheum Dis,2006,65(Suppl 3):iii29-iii33.
• [7]Kirkham BW,Lassere MN,Edmonds JP,et al.Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis:a two-year prospective study(the DAMAGE study cohort)[J].Arthritis Rheum,2006,54:1122-1131.
• [8]Kwok SK,Cho ML,Park MK,et al.Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis[J].Arthritis Rheum,2012,64:740-751.
• [9]van Amelsfort JM,Jacobs KM,Bijlsma JW,et al.CD4(+)CD25(+)regulatory T cells in rheumatoid arthritis:differences in the presence,phenotype,and function between peripheral blood and synovial fluid[J].Arthritis Rheum,2004,50:2775-2785.
• [10]Mttnen M,Heikkinen J,Mustonen L,et al.CD4+CD25+T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis[J].Clin Exp Immunol,2005,140:360-367.
• [11]Lawson CA,Brown AK,Bejarano V,et al.Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood[J].Rheumatology(Oxford),2006,45:1210-1217.
• [12]Ehrenstein MR,Evans JG,Singh A,et al.Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy[J].J Exp Med,2004,200:277-285.
• [13]Nie H,Zheng Y,Li R,et al.Phosphorylation of FOXP3controls regulatory T cell function and is inhibited by TNF-αin rheumatoid arthritis[J].Nat Med,2013,19:322-328.
• [14]Peluso I,Fantini MC,Fina D,et al.IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+T lymphocytes[J].J Immunol,2007,178:732-739.
• [15]Valencia X,Stephens G,Goldbach-Mansky R,et al.TNF downmodulates the function of human CD4+CD25hi T-regulatory cells[J].Blood,2006,108:253-261.
• [16]Atzeni F,Benucci M,SallìS,et al.Different effects of biological drugs in rheumatoid arthritis[J].Autoimmun Rev,2013,12:575-579.
• [17]Nadkarni S,Mauri C,Ehrenstein MR.Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta[J].J Exp Med,2007,204:33-39.
• [18]Mc Govern JL,Nguyen DX,Notley CA,et al.Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy[J].Arthritis Rheum,2012,64:3129-3138.
• [19]Aravena O,Pesce B,Soto L,et al.Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and expands IFN-gamma-producing NK cell and regulatory T cell subsets[J].Immunobiology,2011,216:1256-1263.
• [20]Tanaka T.Can IL-6 blockade rectify imbalance between Tregs and Th17 cells?[J].Immunotherapy,2013,5:695-697.
• [21]Schoels MM,van der Heijde D,Breedveld FC,et al.Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases:systematic literature review and meta-analysis informing a consensus statement[J].Ann Rheum Dis,2013,72:583-589.
• [22]LequerréT,Avenel G,Vittecoq O.Therapeutic update in rheumatoid arthritis[J].Rev Med Intern,2013,34:754-762.
• [23]Hueber W,Patel DD,Dryja T,et al.Effects of AIN457,a fully human antibody to interleukin-17A,on psoriasis,rheumatoid arthritis,and uveitis[J].Sci Transl Med,2010,2:52ra72.doi:10.1126/scitranslmed.3001107.
• [24]Genovese MC,Van den Bosch F,Roberson SA,et al.LY2439821,a humanized anti-interleukin-17 monoclonal antibody,in the treatment of patients with rheumatoid arthritis:a phase I randomized,double-blind,placebo-controlled,proof-of-concept study[J].Arthritis Rheum,2010,62:929-939.
• [25]Solt LA,Kumar N,Nuhant P,et al.Suppression of TH17differentiation and autoimmunity by a synthetic ROR ligand[J].Nature,2011,472:491-494.
• [26]Kelchtermans H,Geboes L,Mitera T,et al.Activated CD4+CD25+regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis[J].Ann Rheum Dis,2009,68:744-750.
• [27]Wright GP,Stauss HJ,Ehrenstein MR.Ehrenstein.Therapeutic potential of Tregs to treat rheumatoid arthritis[J].Semin Immunol,2011,23:195-201.
• [28]Ju JH,Heo YJ,Cho ML,et al.Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells[J].Arthritis Rheum,2012,64:3543-3552.